The Food Standards Agency has issued a warning about certain CBD products.
According to the regulator, an ingredient derived from the cannabis plant should not be consumed pregnant women, breastfeeding mothers and people taking medication.
The FSA has also warned others not to consume more than 70mg of the products a day.
In a bid to make potential side-effects more clear, the agency urges CBD businesses to provide more information on safety.
They are also being asked to apply for “novel food authorisation”.
Those who fail to do so could risk having their products taken off shelves by the end of March 2021.
-
Weed compound 33 TIMES more powerful than normal discovered by scientists
-
Mum who smokes weed every day says it makes her a 'better mum'
FSA chief executive Emily Miles said while such products are "widely available on the high street" they are not properly authorised.
"The CBD industry must provide more information about the safety and contents of these products to the regulator before 31 March 2021, or the products will be taken off the shelves," she said.
"Also today, we are advising that CBD could be risky for vulnerable groups, and suggesting an upper limit of 70mg a day for everyone else taking the product.
"The actions that we're taking today are a pragmatic and proportionate step in balancing the protection of public health with consumer choice.
“It's now up to industry to supply this information so that the public can be reassured that CBD is safe and what it says it is."
-
This capital city has legalised cannabis for personal use – is the UK next?
The CBD market has boomed in recent years.
Extracts from the cannabis plant are sold in a range of products such as oils, confectionery, and drinks.
Cannabidiol does not contain THC, so the products don’t get you “high”.
- Cannabis
Source: Read Full Article